These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 32724459)

  • 1. Flubendazole elicits anti-cancer effects via targeting EVA1A-modulated autophagy and apoptosis in Triple-negative Breast Cancer.
    Zhen Y; Zhao R; Wang M; Jiang X; Gao F; Fu L; Zhang L; Zhou XL
    Theranostics; 2020; 10(18):8080-8097. PubMed ID: 32724459
    [No Abstract]   [Full Text] [Related]  

  • 2. Flubendazole induces mitochondrial dysfunction and DRP1-mediated mitophagy by targeting EVA1A in breast cancer.
    Zhen Y; Yuan Z; Zhang J; Chen Y; Fu Y; Liu Y; Fu L; Zhang L; Zhou XL
    Cell Death Dis; 2022 Apr; 13(4):375. PubMed ID: 35440104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model.
    Chiu HW; Yeh YL; Wang YC; Huang WJ; Ho SY; Lin P; Wang YJ
    Mol Cancer; 2016 Jun; 15(1):46. PubMed ID: 27286975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
    Ünal TD; Hamurcu Z; Delibaşı N; Çınar V; Güler A; Gökçe S; Nurdinov N; Ozpolat B
    Anticancer Agents Med Chem; 2021; 21(3):355-364. PubMed ID: 32767958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rubioncolin C, a natural naphthohydroquinone dimer isolated from Rubia yunnanensis, inhibits the proliferation and metastasis by inducing ROS-mediated apoptotic and autophagic cell death in triple-negative breast cancer cells.
    Li L; Wang J; Feng L; Fan J; Wang J; Tan N; Wang Z
    J Ethnopharmacol; 2021 Sep; 277():114184. PubMed ID: 33961996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy.
    Chang CH; Bijian K; Wernic D; Su J; da Silva SD; Yu H; Qiu D; Asslan M; Alaoui-Jamali MA
    Autophagy; 2019 Aug; 15(8):1376-1390. PubMed ID: 30773992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition.
    Oh E; Kim YJ; An H; Sung D; Cho TM; Farrand L; Jang S; Seo JH; Kim JY
    Int J Cancer; 2018 Oct; 143(8):1978-1993. PubMed ID: 29744876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Flubendazole Inhibits the Proliferation of A549 and H460 Cells and Promotes Autophagy].
    Dong T; Lu Z; Li J; Liu Y; Wen J
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):306-313. PubMed ID: 32429634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy.
    Lin S; Yang L; Yao Y; Xu L; Xiang Y; Zhao H; Wang L; Zuo Z; Huang X; Zhao C
    J Exp Clin Cancer Res; 2019 Jul; 38(1):293. PubMed ID: 31287013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in Vivo.
    Li HC; Xia ZH; Chen YF; Yang F; Feng W; Cai H; Mei Y; Jiang YM; Xu K; Feng DX
    Cell Physiol Biochem; 2017; 43(5):1829-1840. PubMed ID: 29050003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems biology-based discovery of a potential Atg4B agonist (Flubendazole) that induces autophagy in breast cancer.
    Zhang L; Guo M; Li J; Zheng Y; Zhang S; Xie T; Liu B
    Mol Biosyst; 2015 Nov; 11(11):2860-6. PubMed ID: 26299935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/ Src signaling in triple negative breast cancer cells.
    Hamurcu Z; Delibaşı N; Geçene S; Şener EF; Dönmez-Altuntaş H; Özkul Y; Canatan H; Ozpolat B
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):415-430. PubMed ID: 29288363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paris saponin VII inhibits triple-negative breast cancer by targeting the MEK/ERK/STMN1 signaling axis.
    Zhang Y; Wei S; Zhang Q; Zhang Y; Sun C
    Phytomedicine; 2024 Jul; 130():155746. PubMed ID: 38763012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 20(R)-Panaxatriol enhances METTL3-mediated m
    Li Y; Luo B; Lin X; Bai D; Li L; Gao D; Li X; Zhong X; Wei Y; Yang L; Zhu X; Han L; Tian H; Zhang R; Wang P
    Phytomedicine; 2024 Jul; 130():155537. PubMed ID: 38823344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel combinatorial autophagy inhibition therapy for triple negative breast cancers.
    Abd El-Aziz YS; Toit-Thompson TD; McKay MJ; Molloy MP; Stoner S; McDowell B; Moon E; Sioson L; Sheen A; Chou A; Gill AJ; Jansson PJ; Sahni S
    Eur J Pharmacol; 2024 Jun; 973():176568. PubMed ID: 38604544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer.
    Bousquet G; El Bouchtaoui M; Sophie T; Leboeuf C; de Bazelaire C; Ratajczak P; Giacchetti S; de Roquancourt A; Bertheau P; Verneuil L; Feugeas JP; Espié M; Janin A
    Oncotarget; 2017 May; 8(21):35205-35221. PubMed ID: 28445132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SANT, a novel Chinese herbal monomer combination, decreasing tumor growth and angiogenesis via modulating autophagy in heparanase overexpressed triple-negative breast cancer.
    Li QW; Zhang GL; Hao CX; Ma YF; Sun X; Zhang Y; Cao KX; Li BX; Yang GW; Wang XM
    J Ethnopharmacol; 2021 Feb; 266():113430. PubMed ID: 33011366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
    Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
    Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
    Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ
    Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing mebendazole against triple-negative breast cancer CNS metastasis.
    Rodrigues AJ; Chernikova SB; Wang Y; Trinh TTH; Solow-Cordero DE; Alexandrova L; Casey KM; Alli E; Aggarwal A; Quill T; Koegel AK; Feldman BJ; Ford JM; Hayden-Gephart M
    J Neurooncol; 2024 May; 168(1):125-138. PubMed ID: 38563850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.